Schedule 13G ownership disclosure

Intellia Therapeutics Inc

COMMON STOCK · CUSIP: 45826J105

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Contrarius Investment Management Ltd

    Shares: 5,889,936.00 · Class: 5.5%

  • Contrarius Investment Management (Bermuda) Ltd

    Shares: 5,889,936.00 · Class: 5.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001999371-25-017496
Form type
SCHEDULE 13G
Filer
Contrarius Investment Management Ltd
CIK
CIK 1483738
Filed
Nov 12, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub